Research article · 15 Apr 2026
Conference abstractPublished 20 Aug 2012
The efficacy and biocompatibility of a novel polymer-based solution in a rat model of acute peritoneal dialysis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Peritoneal dialysis (PD) for treating renal end-stage disease is limited by the bioincompatibility of conventional glucose-based lactate-buffered solutions. The present study was to test the biocompatibility of a novel polymer molecule as a primary osmotic agent in acute PD. Materials and Methods: Spragle-Dawley rats were used as a preclinical model of acute PD. Peritoneal injury and cellular infiltration were determined by both histology and flow cytometric analysis. Results: Here we showed that intraperitoneal administration of polymer solutions significantly induced fluid removal in a concentration-dependent manner. As compared to conventional PD solution (Dianeal? 2.5%), polymer solutions at the concentration of 15% removed more fluid, and at both 7.5% and 15% retained more urea, indicated by the higher amount of net urea in the effluents or higher urea clearance rates during 4 hrs of dialysis. Histological examination indicated that the peritoneal membrane injury along with polymorphonuclear infiltrates in rats with polymer solutions was milder than those with conventional PD solution. These observations were further confirmed by the presence of fewer neutrophils and peritoneal mesothelial cells in the recovered polmer solutions. In cultured human peritoneal mesothelial cells, more cells survived following exposure to polymer solutions than those to conventional PD solution that induced cytoplasmic vacuolation. Conclusion: Our data indicated that polymer solution was superior to conventional glucose-based PD solution both in the removal of fluid and urea, and in peritoneum tolerance, suggesting the potential of this polymer as an osmotic agent for developing a new PD solution.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Caigan Du”
- BylineArticles whose byline prints “Asher Mendelson”
- BylineArticles whose byline prints “Qiunong Guan”
- BylineArticles whose byline prints “Gerald A. da Roza”
- BylineArticles whose byline prints “Jayachandran N. Kizhakkedathu”
